Skip to main content
. 2020 Jul 2;99(27):e20944. doi: 10.1097/MD.0000000000020944

Figure 1.

Figure 1

Expression of integrin-beta 1 and cellular proliferation of LS174T cells. (A) Expression of integrin-beta 1 in LS174T cells in each group without cetuximab treatment. (B) Cellular proliferation of LS174T cells in each group under cetuximab treatment. Each experiment was repeated for 3 times independently. Data was presented as mean ± SD. P < .05 was set as a statistic difference. P < .05 compared with normal control group, #P < .05 compared with cetuximab treatment group.